{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:18:05Z","timestamp":1760242685229},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.2546","type":"journal-article","created":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T01:11:49Z","timestamp":1412125909000},"page":"2211-2214","source":"Crossref","is-referenced-by-count":20,"title":["Epithelioid Inflammatory Myofibroblastic Sarcoma Responsive to Surgery and an ALK Inhibitor in a Patient with Panhypopituitarism"],"prefix":"10.2169","volume":"53","author":[{"given":"Kotomi","family":"Kurihara-Hosokawa","sequence":"first","affiliation":[{"name":"Department of Metabolism and Endocrinology, Osaka City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Kawasaki","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Endocrinology, Osaka City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Tamai","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Endocrinology, Osaka City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Endocrinology, Osaka City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Yakushiji","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Endocrinology, Osaka City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Ueno","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Endocrinology, Osaka City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Endocrinology, Osaka City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Osaka City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Pathology, Osaka City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Hosoi","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Endocrinology, Osaka City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Gleason CA, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol 61: 428-437, 2008.","DOI":"10.1136\/jcp.2007.049387"},{"key":"2","unstructured":"2. Griffin CA, Hawkins AL, Dvorak C, et al. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. Cancer Res 59: 2776-2780, 1999."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Morris SW, Naeve C, Mathew P, James PL, Kirstein MN, Cui X, Witte DP. ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 14: 2175-2188, 1997.","DOI":"10.1038\/sj.onc.1201062"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lawrence B, Perez-Atayde A, Hibbard MK, et al. TPM3-ALK and TPM4-ALK oncogene in inflammatory myofibroblastic tumors. Am J Pathol 157: 377-384, 2000.","DOI":"10.1016\/S0002-9440(10)64550-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Pulford K, Morris SW, Turturro F. Anaplastic lymphoma kinase protein in growth control and cancer. J Cell Physiol 199: 330-358, 2004.","DOI":"10.1002\/jcp.10472"},{"key":"6","unstructured":"6. Marino-Enriquez A, Wang WL, Roy A, et al. Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Am J Surg Pathol 35: 135-144, 2011."},{"key":"7","unstructured":"7. Chen ST, Lee JC. An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features. Hum Pathol 39: 1854-1858, 2008."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ma Z, Hill DA, Collins MH, et al. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 37: 98-105, 2003.","DOI":"10.1002\/gcc.10177"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Patel AS, Murphy KM, Hawkins AL, et al. RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors. Cancer Genet Cytogenet 176: 107-114, 2007.","DOI":"10.1016\/j.cancergencyto.2007.04.004"},{"key":"10","unstructured":"10. Cook JR, Dehner LP, Collins MH, et al. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibloblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol 25: 1364-1371, 2001."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Butrynski JE, D'Adamo DR, Hornic JL, et al. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med 363: 1727-1733, 2010.","DOI":"10.1056\/NEJMoa1007056"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/19\/53_53.2546\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:52:29Z","timestamp":1621446749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/19\/53_53.2546\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":11,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.2546","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}